| [1] |
CHEN Xiaodan, ZHOU Shu, LYU Yanru, XU Zhiyong, LAN Haiyan, LU Shui, GAO Shan, SHU Liuyang, LIN Siyang, HAO Yanrong, XIE Yanyan.
Study on the initial titration dose and genetic polymorphism of oxycodone hydrochloride prolonged-release tablets in the treatment of severe cancer pain
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 74-80.
|
| [2] |
JIA Chensi, WANG Xiaohong, ZHOU Yang, ZHANG Jinghua .
Research progress on capsular contracture after breast implant reconstruction in patients with breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 115-120.
|
| [3] |
Tumor Gene Diagnosis Committee of the China Anti⁃Cancer Association, Integrative Oncology Branch of the China Anti⁃Cancer Association.
Chinese expert consensus on the localization of bioinformatics analysis for tumor genetic diagnosis using next⁃generation sequencing (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 638-649.
|
| [4] |
The Society of Medical Ethics of China Anti⁃Cancer Association.
Chinese expert consensus on compensation management for research participants in clinical trials of cancer (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 650-655.
|
| [5] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
| [6] |
LI Bingbing, XU Ke .
Role of m7G methyltransferase METTL1 in tumor and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 747-752.
|
| [7] |
LI Siyuan, ZHANG Yan, ZHANG Lu.
Application and challenge of CAR-T cell therapy in autoimmune diseases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 516-524.
|
| [8] |
LIU Jingqian, ZHANG Yajing.
Strategies for prevention,control and management of CAR-T cell therapy related adverse reactions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 540-548.
|
| [9] |
SUN Yifei, GAO Wen, JIA Junlei, ZHANG Huilai, YU Jingwei, WANG Xianhuo.
Safety of CD19 CAR-T therapy: Signal mining and analysis of adverse events based on FAERS database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 554-561.
|
| [10] |
DI Yingjie, XUE Yaoqin, REN Jinrui, OU Aixin, LIU Yue .
Research progress on the mechanism of Pirfenidone anti-tumor action
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 494-498.
|
| [11] |
AN Pingping, FAN Ruyu, ZHOU Shijin, YE Xuanxuan, WU Cong .
Research progress on the mechanisms of Per gene in tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 354-360.
|
| [12] |
ZHANG Jiayuan, LIU Li, ZHOU Yuqiu.
Research progress on help-seeking behaviour for cancer symptoms of cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 380-384.
|
| [13] |
Tumor marker committee of Chinese anti?cancer association.
Expert Consensus on detection and clinical application of tumor DNA methylation markers (Version 2024)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 129-142.
|
| [14] |
XIAN Shinan, MO Yingxi, WANG Shan, YANG Yiping, ZHANG Qingyun.
Role of protein phosphatase 4 catalytic subunit in tumor progression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 249-254.
|
| [15] |
WANG Huilin, JIANG Wei, YU Qitao.
Progress in the application of patient?reported outcomes in tumor immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 255-260.
|
